These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3509945)

  • 41. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition.
    Perry LL; Greene MI
    J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.
    Kobayashi K; Allred C; Yoshida T
    J Immunol; 1985 Nov; 135(5):2996-3003. PubMed ID: 2931477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Loss-of-Function Screens Reveal ABCE1 as an Essential Cellular Host Factor for Efficient Translation of
    Anderson DE; Pfeffermann K; Kim SY; Sawatsky B; Pearson J; Kovtun M; Corcoran DL; Krebs Y; Sigmundsson K; Jamison SF; Yeo ZZJ; Rennick LJ; Wang LF; Talbot PJ; Duprex WP; Garcia-Blanco MA; von Messling V
    mBio; 2019 May; 10(3):. PubMed ID: 31088929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of heterogenized cellular antigens in cross immunity reactions in paramyxovirus infections].
    Pokryshkina EL; Fedorova OE; Lozovskaia LS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):45-9. PubMed ID: 106603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The paramyxoviridae: aspects of molecular structure, pathogenesis, and immunity.
    Vainionpää R; Marusyk R; Salmi A
    Adv Virus Res; 1989; 37():211-42. PubMed ID: 2690597
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lymphocytic sensitization to antigens of viruses of the family Paramyxoviridae in diabetes mellitus].
    Asfandiyarova NS; Shatrov VV; Garipov GK
    Probl Endokrinol (Mosk); 2006 Dec; 52(6):18-21. PubMed ID: 31627662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-reactivity between T cells and bacteria.
    Wölk U; Meyer TF
    Allergy; 1999 Sep; 54(9):1010-1. PubMed ID: 10505472
    [No Abstract]   [Full Text] [Related]  

  • 49. Serological cross-reactivity between viruses and their contribution to autoimmunity.
    Vojdani A; Monro J; Lanzisera F; Sadeghi H
    Autoimmun Rev; 2021 Jul; 20(7):102840. PubMed ID: 33971342
    [No Abstract]   [Full Text] [Related]  

  • 50. Alterations in Delayed Hypersensitivity Produced by Live Attenuated Measles Virus in Man.
    Hildreth EA; Frederic MW; Randall P
    Trans Am Clin Climatol Assoc; 1964; 75():37-51. PubMed ID: 21408630
    [No Abstract]   [Full Text] [Related]  

  • 51. T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.
    Harris KM; Horn SE; Grant ML; Lang H; Sani G; Jensen-Wachspress MA; Kankate VV; Datar A; Lazarski CA; Bollard CM; Keller MD
    Front Immunol; 2020; 11():575977. PubMed ID: 33123159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.
    Do LAH; Tsedenbal N; von Mollendorf C; Mungun T; Bardach D; Mulholland K
    J Infect Dis; 2021 Oct; 224(7):1266-1268. PubMed ID: 32103234
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    Do VA; Biering-Sørensen S; Fisker AB; Balé C; Rasmussen SM; Christensen LD; Jensen KJ; Martins C; Aaby P; Benn CS
    J Infect Dis; 2017 Apr; 215(8):1188-1196. PubMed ID: 28077730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.
    Sørup S; Benn CS; Stensballe LG; Aaby P; Ravn H
    Vaccine; 2015 Jan; 33(1):237-45. PubMed ID: 25446818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T cell cross-reactivity among viruses of the paramyxoviridae.
    Ziola B; Smith RH
    Viral Immunol; 1987; 1(2):111-9. PubMed ID: 3509945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies against the nucleoprotein of mumps virus: their binding characteristics and cross-reactivity with other paramyxoviruses.
    Tsurudome M; Yamada A; Hishiyama M; Ito Y
    Acta Virol; 1990 May; 34(3):220-7. PubMed ID: 1980395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
    Vaidya SR; Kumbhar NS; Bhide VS
    Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T lymphocyte interaction with viruses and virus-infected tissues.
    Woodruff JF; Woodruff JJ
    Prog Med Virol; 1975; 19():120-60. PubMed ID: 47179
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.